(30) D. Seidlova-Wuttke, J. Christoffel, G. Rimoldi, H. Jarry, and W. Wuttke, Comparison of effec ts of es- tradiol with those of octylmethoxycinnamate and 4-methylbenzylidene camphor on fat tissue, lipids and pituitary hormones, Toxicol. Appl. Pharmacol., 214, 1–7 (2006). (31) J. Wang, L. Pan, S. Wu, L. Lu, Y. Xu, Y. Zhu, M. Guo, and S. Zhuang, Recent advances on end o crine disrupting effects of UV fi lters, Int. J. Environ. Res. Publ. Health, 13, 782 (2016). (32) M. Krause, A. Klit, M. Blomberg Jensen, T. Søeborg, H. Frederiksen, M. Schlumpf, W. Lichten s teiger, N. E. Skakkebaek, and K. T.Drzewiecki, Sunscreens: are they benefi cial for health? An overview of en- docrine disrupting properties of UV-fi lters, Int. J. Androl., 35, 424–436 (2012). (33) M. K. Matta, J. Florian, R. Zusterzeel, N. R. Pilli, V. Patel D. A. Volpe, Y. Yang, L. Oh, E. Basha w, I. Zineh, C. Sanabriaand, S. Kemp, A. Godfrey, S. Adah, S. Coelho, J. Wang, L.-A. Furlong, C. Ganley, T. Michele, and D. G. Strauss, Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial, J. Am. Med. Assoc., 323(3), 256–267 (2020). (34) H. Frederiksen, M. Krause, N. Jørgensen, A. Rehfeld, N. E. Skakkebæk, and A. M. Andersson, UV fi lt e rs in matched seminal fl uid-, urine-, and serum samples from young men, J. Expo. Sci. Environ. Epidemiol., 31, 345–355 (2020). (35) J. D. Bos and M. M. Meinardi, The 500 Dalton rule for the skin penetration of chemical compounds and drugs, Exp. Der m atol., 9, 165–169 (2009). (36) F. Benech-Kieffer, P. Wegrich, R. Schwarzenbach, G. Klecak, T. Weber, J. Leclaire, and H. Schaefer, Percutaneous ab s orption of sunscreens in vitro, interspecies comparison, skin models and reproducibility aspects, Appl. Skin Physiol., 13, 324–335 (2000). (37) L. Roussel, E. Gilbert, D. Salmon, C. Serre, B. Gabard, M. Haftek, H. I. Maibach, and F. Pirot, Measurement, analysis a nd prediction of topical UV fi lter bioavailability, Int. J. Pharm., 478(2), 804–810 (2015). (38) M. Vettor, S. Bourgeois, H. Fessi, J. Pelletier, P. Perugini, F. Pavanetto, and M. A. Bolzinger, Skin ab- sorption studi e s of octyl-methoxycinnamate loaded poly(D,L-Lactide) nanoparticles, estimation of the UV fi lter distribution and release behaviour in skin layers, J. Microencapsul., 27, 253–262 (2010). (39) G. J. Nohynek, E. K. Dufour, and M. S. Roberts, Nanotechnology, cosmetics, and the skin, is there a health risk? Skin P harmacol. Physiol., 21, 136–149 (2008). (40) C. G. J Hayden, S. E Cross, C. Anderson, N. A. Saunders, and M. S. Roberts, Sunscreen penetration of human skin and rel ated keratinocyte toxicity after topical application, Appl. Skin Physiol., 18, 170–174 (2005). (41) T. Søeborg, L.H. Basse, B. Halling-Sørensen, Risk assessment of topically applied products, Toxicology, 236, 140–148 (2007). (42) L. Montenegro, R. Turnaturi, C. Parenti, and L. Pasquinucci, In vitro evaluation of sunscreen safety, effects of the v e hicle and repeated applications on skin permeation from topical formulations, Pharmaceutics, 10, 27 (2018). (43) S. L. Schneider and H. W. Lim, A review of inorganic UV fi lters zinc oxide and titanium dioxide, Pho- todermatol. Photoi m munol. Photomed., 35(6), 442–446 (2019). (44) K. Adachi, N. Yamada, Y. Yoshida, and O. Yamamoto, Subchronic exposure of titanium dioxide nanoparticles to hairless r at skin, Exp. Dermatol., 22, 278–283 (2013). (45) N. Sadrieh, A. M. Wokovich, N. V. Gopee, J. Zheng, D. Haines, D. Parmiter, P. H. Siitonen, C. R. Cozart, A. K. Patri, S . E. McNeil, P. C. Howard, W. H. Doub, and L. F. Buhse, Lack of signifi cant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size Tio2 particles, Toxicol. Sci., 115, 156–166 (2010). (46) I. Karlsson, L. Hillerström, A. L., Stenfeldt, J. Mårtensson, and A. Börje, Photodegradation of dibenzoyl- methanes, poten t ial cause of photocontact allergy to sunscreens, Chem. Res. Toxicol., 22, 1881–1892 (2009). (47) G. J. Mturi and B. S. Martincigh, Photostability of the sunscreening agent 4- tert-butyl-4′- methoxydibenzoylmethane (avobenzone) in solvents of di f ferent polarity and proticity, Photochem. Photobiol., 200, 410–420 (2008). (48) A. M. Bryden, H. Moseley, S. H. Ibbotson, M. M. U. Chowdhury, M. H. Beck, J. Bourke, J. English, P. Farr, I. S. Foulds, D. J. Gawkrodger, S. George, D. I . Orton, S. Shaw, J. McFadden, P. Norris, P. Podmore, S. Powell, L. E. Rhodes, J. Sansom, M. Wilkinson, H. van Weelden, and J. Ferguson, Photopatch testing of 1155 patients, results of the U.K. multicentre photopatch study group, Br. J. Dermatol., 155, 737– 747 (2006). (49) H. Gustavsson Gonzalez, A. Farbrot, and O. Larkö, Percutaneous absorption of benzophenone-3, a common component of topical sunscreens, Clin. Exp. Dermato l ., 27, 691–694 (2002). (50) N. R. Janjua, B. Kongshoj, A. M. Andersson, and H. C. Wulf, Sunscreens in human plasma and urine after repeated whole-body topical application, J. Eur. Acad. De r matol. Venereol., 22, 456–461 (2008). JOURNAL OF COSMETIC SCIENCE 322
(51) M. Schlumpf, K. Kypke, M. Wittassek, J. Angerer, H. Mascher, D. Mascher, C. Vokt, M. Birchler, and W. Lichtensteiger, Exposure patterns of UV-fi lters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: correlation of UV-fi lters with use of cosmetics, Chemo- sphere, 81, 1171–1183 (2010). (52) T. M. Hughes and N. M. Stone, Benzophenone 4, an emerging allergen in cosmetics and toiletries? Contact Dermatitis, 56, 153–156 (2007). (53) A. R. Heurung, S. I. Raj u , and E. M. Warshaw, Benzophenones, Dermatitis, 25, 3–10 (2014). (54) B. S. Mackie and L. E. Mackie, The PABA story, Australas. J. Dermatol., 40, 51–53 (1999). (55) A. J. Waters, D. R. Sandhu, G. Lowe, and J. Ferguson, Photocontact alle r gy to paba in sunscreens, the need for continued vigilance, Contact Dermatitis, 60, 172–173 (2 0 09). (56) J. Greenspoon, R. Ahluwalia, N. Juma, and C. F. Rosen, Allergic and photoallergic contact dermatitis, a 10-year experience. Dermatitis, 24, 29–32 (2013). (57) E. Chat e lain, B. Gabard, and C. Surber, Skin penetration and sun protection factor of fi ve uv fi lters, ef- fect of the vehicle, Appl. Skin Physiol., 6, 28–35 (2003). (58) R. Rai, S. C. Shanmuga, and C. R. Srinivas, Update on photoprotection, Indian J. Dermatol., 57, 335– 342 (2012). (59) S. Séite, D. Moyal, S. Richard, J. De Rigal, J. L. L é vêque, C. Hourseau and A. Fourtanier, and S. X. Mexoryl, A broad absorption UVA fi lter protects human skin from the effects of repeated suberythemal doses of UVA, J. Photochem. Photobiol. B, 44, 69–76 (1998). (60) A. Fourtanier, D. Moyal, and S. Seité, Sunscreens containing the broad-spectrum uva absorber, mexoryl sx, prevent the cutaneous detrimental effects of uv exposure, a review of clini c al study results, Photoder- matol. Photoimmunol. Photomed., 24, 164–174 (2008). (61) S. Fatima, T. Braunberger, T. F. Mohammad, I. Kohli, and I. H. Hamzavi, The role of sunscreen in melasma and postinfl ammatory hyperpigmentation, Indian J. Dermatol., 65, 5–10 (2020). (62) F . Benech-Kieffer, W. J. Meuling, C. Leclerc, L. Roza, J. Leclaire, and G. Nohynek, Percutaneous ab- sorption of Mexoryl SX in human volunteers: comparison with in vitro data, Appl. Skin Phy s iol., 16(6), 343–355 (2003). (63) A. Necasova, K. Banyiova, J. Literak, and P. Cupr, New probabilistic risk assessment of ethylhexyl methoxycinnamate: comparing the genotoxic effects of trans- and cis-EHMC, Environ. Toxico l ., 32, 569–580 (2017). (64) A. Sharma, K. Bányiová, P. Babica, N. El Yamani, A. R. Collins, and P. Čupr, Different DNA damage response of cis and trans isomers of commonly used UV fi lter after the exposure on adult hu m an liver stem cells and human lymphoblastoid cells, Sci. Total Environ., 593–594, 18–26 (2017). (65) A. Sharma, K. Bányiová, B. Vrana, I. Justan, and P. Čupr, Investigation of cis-trans isomer dependent dermatotoxicokinetics of uv fi lter ethylhexyl methoxycinnamate through stratum corneum in vivo, Environ. Sc i . Pollut. Res. Int., 24, 25061–25070 (2017). (66) E. Berardesca, T. Zuberbier, M. Sanchez Viera, and M. J. Marinovich, Review of the safety of octocrylene used as an ultraviolet fi lter in cosmetics, Eur Acad Dermatol Venereol, 33(Suppl 7), 25–33 (2019). (67) C. Puglia, F . Bonina, L. Rizza, P. Blasi, A. Schoubben, R. Perrotta, M. S. Tarico, and E. Damiani, Lipid nanoparticles as carrier for octyl-methoxycinnamate, in vitro percutaneous absorption and photostabil- ity studies, J. Pharmacol. Sci., 101, 301–311 (2012). (68) C. Puglia, E. Damiani, A. Offerta, L. Rizza, G. G. Tirendi, M. S. Tarico, S. Curreri, F. Bonina, and R. E. Perrotta, Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-fi lters, characte r ization, in vitro penetration and photostability studies, Eur. J. Pharmaceut. Sci., 51, 211–217 (2014). (69) A. C. Cozzi, P. Perugini, and S. Gourion-Arsiquaud, Comparative behavior between sunscreens based on free or encapsulated uv fi lters in term of skin penetration, retention and photo-stability, Eur. J. Pharma- ceut. Sci., 12 1 , 309–318 (2018). (70) Z. Klimová, J. Hojerová, and M. Beránková, Skin absorption and human exposure estimation of three widely discussed UV fi lters in sunscreens--In vitro study mimicking real-life consumer habits. Food Chem. Toxicol., 83, 237 250 (2015). (71) D. Monti, I. Brini, S. Tampucci, P. Chetoni, S. Burgalassi, D. Paganuzzi, and A. Ghirardini, Skin per- meation and distribution of two sunscreens, a comparison between reconstituted human skin and hair- less rat skin, Skin Pharmacol. Physiol., 21, 318–325 (2008). (72) C. Souza and P. M. B. G. Maia Campos, Development of a HPLC method for determination of four UV fi lters in sunscreen and its application to skin penetration studies, Biomed. Chromatogr., 12, e4499 (2017). (73) Y. Qiao, H. Dong, and X. Zhang, Versatile sunscreen with minimal ROS damage and low permeability, Appl Mater Interf., 12, 6217–6225 (2020). DISTRIBUTION OF UV FILTERS ON THE SKIN 323
Previous Page Next Page